Shanghai Bovax Biotechnology Co., Ltd.

This study is testing a new HPV vaccine designed to protect against 15 types of the human papillomavirus. It will involve 330 healthy volunteers in China, aged 9 to 45 years old. Researchers will compare the new vaccine to a placebo and an existing vaccine to check how safe it is…